Skip to main navigation Skip to search Skip to main content

Translating pharmacokinetic and pharmacodynamic data to better design new drugs for the treatment of Trypanosoma cruzi infection

  • Charman, Susan (Primary Chief Investigator (PCI))
  • Avery, Vicky M (Chief Investigator (CI))
  • Best, Wayne (Partner Investigator (PI))
  • Chatelain, Eric (Partner Investigator (PI))
  • Keenan, Martine (Partner Investigator (PI))
  • Kelly, John Morrison (Partner Investigator (PI))

Project: Research

Project Details

Project Description

This project will develop new tools and approaches to enhance drug discovery for Chagas disease, a serious, chronic illness endemic in countries of poverty and poorly treated by available drugs. Through the strategic application of these new tools, we will identify new drug candidates suitable for further development.
StatusFinished
Effective start/end date6/01/15 → 30/06/17

Funding

  • ARC - Australian Research Council: A$507,000.00
  • DNDi - Drugs for Neglected Diseases Initiative: A$1,306,535.00